A New Vaccine For Shigella Sonnei That Is The Leading Cause Of Shigella In The U.S. And In Most Developed Countries World-wide
Patent Cooperation Treaty
PCT/US2009/053897
Filed on 2009-08-14
PCT/US2009/053897
Filed on 2009-08-14
Detection and Quantification of HIV Antigen
Patent Cooperation Treaty
PCT/US09/051440
Filed on 2009-07-22
PCT/US09/051440
Filed on 2009-07-22
Stabilization Of Complexes For GeI Mobility Shift, Chromatography, And Capillary Electrophoresis
US Application 12/485,481
Filed on 2009-06-16
Filed on 2009-06-16
Orally Active Peptides that Prevent Cell Damage and Death
Luxembourg
00957607.5
Filed on 2000-08-17
00957607.5
Filed on 2000-08-17
Orally Active Peptides that Prevent Cell Damage and Death
Ireland
00957607.5
Filed on 2000-08-17
00957607.5
Filed on 2000-08-17
GOSSYPOL FOR THE TREATMENT OF CANCER
US Application 12/426,841
Filed on 2009-04-20
Filed on 2009-04-20
17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as Antiprogestational Agents
European Patent
08009259.6
Filed on 2001-03-16
08009259.6
Filed on 2001-03-16
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Canada
2668824
Filed on 1997-04-30
2668824
Filed on 1997-04-30
Biomarkers for niemann-pick C disease and related disorders
US Patent 8,497,122
Filed on 2009-04-10
Filed on 2009-04-10
VACCINE AGAINST ESCHERICHIA COLI 0157 INFECTION
US Patent 8,168,195
Filed on 2009-05-22
Filed on 2009-05-22